April 24, 2024
U.S. Acellular Dermal Matrices Market

U.S. acellular dermal matrices, also known as acellular dermal matrix (ADM) or acellular dermal graft (ADG), are sterile tissue allografts derived from human or mammalian skin and are an important tool for reconstructive and plastic surgery procedures. ADMs are processed to remove cellular components while leaving behind important extracellular proteins that promote revascularization and host cell repopulation. They provide strength and durability in soft tissue reconstruction using a natural tissue matrix that’s reabsorbed and replaced over time by the body’s own collagen. ADMs offer advantages over autografts such as lower donor site morbidity and are often used as an alternative to autografts in breast reconstruction procedures post mastectomy.

The U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 3206.39 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the U.S. Acellular Dermal Matrices are USAntibiotics, Dr. Reddy€TMs Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Ralington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare.

The acellular dermal matrices market is driven by the growing demand for reconstructive surgical procedures such as breast reconstruction post-mastectomy. ADMs offer advantages over autografts by reducing donor site morbidity and post-operative pain and have higher success rates in reconstructive surgeries.

Globally, the market is witnessing expansion fueled by an increasing prevalence of cancer and rapidly growing geriatric population facing age-related wounds and injuries. Emerging countries in Asia Pacific and Latin America with growing medical tourism industries also present lucrative opportunities for players in the U.S. acellular dermal matrices market.

Market key trends

One of the key trends gaining prominence in the U.S. acellular dermal matrices market is the increasing adoption of tissue-engineered matrices over traditional acellular dermal matrices. Tissue-engineered matrices incorporate tissue-engineering strategies to enrich ADMs with regenerative cell types or growth factors that promote faster skin and soft-tissue regeneration. This allows for shorter recovery periods and better cosmetic outcomes in breast reconstruction and other surgical procedures. Tissue-engineered matrices are next-generation products bringing more advanced solutions to challenges faced by reconstructive and plastic surgeons.

Porter’s Analysis

Threat of new entrants: Low barrier of entry in terms of capital requirement and technology. However, the market is dominated by few large players.

Bargaining power of buyers: Moderate bargaining power. Buyers have many suppliers to choose from. However, switching costs are involved for buyers.

Bargaining power of suppliers: Moderate bargaining power. Suppliers have product differentiation but face threat from substitutes.

Threat of new substitutes: High threat. Substitutes exist in form of biosynthetic skin substitute matrices used for soft tissue repair.

Competitive rivalry: Intense competition. Major players compete on different parameters like innovation, quality, and pricing.

The geographical region where the value of U.S. Acellular Dermal Matrices Market is concentrated is North America. With increasing aging population and chronic wound patient base along with favorable reimbursement policies, the North American region accounts for the major share in the market value.

The fastest growing geographical region for U.S. Acellular Dermal Matrices Market is Asia Pacific. Factors such as rising medical tourism, growing health awareness, increasing healthcare spending, and expanding private healthcare infrastructure are contributing to the robust growth of the market in the Asia Pacific region.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it